Thrombin

Results: 300



#Item
91Functional Phenotyping of Human Plasma Using a 361-Fluorogenic Substrate Biosensing Microarray Dhaval N. Gosalia,1 William S. Denney,2 Cleo M. Salisbury,3 Jonathan A. Ellman,3 Scott L. Diamond1,2 1

Functional Phenotyping of Human Plasma Using a 361-Fluorogenic Substrate Biosensing Microarray Dhaval N. Gosalia,1 William S. Denney,2 Cleo M. Salisbury,3 Jonathan A. Ellman,3 Scott L. Diamond1,2 1

Add to Reading List

Source URL: www.seas.upenn.edu

Language: English - Date: 2013-10-11 11:13:16
92Downloaded from http://mp.bmj.com/ on February 25, [removed]Published by group.bmj.com  I Clin Pathol: Mol Pathol 1995;48:M285-M288 M285

Downloaded from http://mp.bmj.com/ on February 25, [removed]Published by group.bmj.com I Clin Pathol: Mol Pathol 1995;48:M285-M288 M285

Add to Reading List

Source URL: mp.bmj.com

Language: English
93V:�TRICT�ER�FT 09�g[removed]wpd

V:TRICTERFT 09g[removed]wpd

Add to Reading List

Source URL: seattletrademarklawyer.com

Language: English - Date: 2009-12-13 22:19:47
94Coagulation simplified ...  tissue factor phospholipid Ca++ Ca++ Ca++

Coagulation simplified ... tissue factor phospholipid Ca++ Ca++ Ca++

Add to Reading List

Source URL: www.instandev.de

Language: English - Date: 2009-07-22 05:30:33
95List of medicinal products marketed by LFB BIOMEDICAMENTS, in France. (By alphabetical order): ACLOTINE® 100 IU/ml – Human antithrombin ALFALASTIN® 33.33 mg/ml – Human alpha-1 antitrypsin

List of medicinal products marketed by LFB BIOMEDICAMENTS, in France. (By alphabetical order): ACLOTINE® 100 IU/ml – Human antithrombin ALFALASTIN® 33.33 mg/ml – Human alpha-1 antitrypsin

Add to Reading List

Source URL: www.lfb.fr

Language: English - Date: 2013-02-11 10:35:59
962014 ASH Annual Meeting Special Scientific Symposium on RNA Therapeutics in Hematology RNAi Therapeutics for Hemophilia and Complement-Related Diseases Akin Akinc, PhD

2014 ASH Annual Meeting Special Scientific Symposium on RNA Therapeutics in Hematology RNAi Therapeutics for Hemophilia and Complement-Related Diseases Akin Akinc, PhD

Add to Reading List

Source URL: www.alnylam.com

Language: English - Date: 2014-12-08 15:55:27
972014 ASH Annual Meeting 322. Disorders of Coagulation or Fibrinolysis: Novel Hemostatic Therapies and Assays A Subcutaneously Administered Investigational RNAi Therapeutic (ALN-AT3) Targeting Antithrombin for Treatment o

2014 ASH Annual Meeting 322. Disorders of Coagulation or Fibrinolysis: Novel Hemostatic Therapies and Assays A Subcutaneously Administered Investigational RNAi Therapeutic (ALN-AT3) Targeting Antithrombin for Treatment o

Add to Reading List

Source URL: www.alnylam.com

Language: English - Date: 2014-12-09 06:39:28
98Haemophilia (2008), 14, 1190–1200  DOI: [removed]j[removed]01857.x ORIGINAL ARTICLE

Haemophilia (2008), 14, 1190–1200 DOI: [removed]j[removed]01857.x ORIGINAL ARTICLE

Add to Reading List

Source URL: www.hemophilia.org

Language: English - Date: 2014-04-22 11:47:01
99Microsoft Word - HAE[removed]Fig 2.doc

Microsoft Word - HAE[removed]Fig 2.doc

Add to Reading List

Source URL: www.hemophilia.org

Language: English - Date: 2014-04-22 11:47:01
100Haemophilia (2008), 14, 1151–1158  DOI: [removed]j[removed]01831.x ORIGINAL ARTICLE

Haemophilia (2008), 14, 1151–1158 DOI: [removed]j[removed]01831.x ORIGINAL ARTICLE

Add to Reading List

Source URL: www.hemophilia.org

Language: English - Date: 2014-04-22 11:47:00